Navigation Links
Genetic 'Roadmap' Charts Links Between Drugs and Human Disease

A research team led by scientists at the Broad Institute of MIT and Harvard announced today the development of a new kind of genetic “roadmap” that can connect human diseases// with potential drugs to treat them, as well as predict how new drugs work in human cells. Called the 'Connectivity Map,' the new tool and its uses are described in the September 29 issue of Science and in separate publications in the September 28 immediate early edition of Cancer Cell. The three papers show the map’s ability to accurately predict the molecular actions of novel therapeutic compounds and to suggest ways that existing drugs can be newly applied to treat diseases such as cancer. Based on the results, the papers propose a public project to expand this initial human Connectivity Map — in the spirit of the Human Genome Project — to accelerate the search for new drugs to treat disease.

'The Connectivity Map works much like a Google search to discover connections among drugs and diseases,' said senior author Todd Golub, the director of the Broad Institute’s Cancer program, an investigator at the Dana-Farber Cancer Institute, an associate professor of pediatrics at Harvard Medical School, and an investigator at the Howard Hughes Medical Institute. 'These connections are notoriously difficult to find in part because drugs and diseases are characterized in completely different scientific languages.'

A key challenge in biomedicine is to connect each human disease with drugs that effectively treat it and to understand the molecular basis for such drugs’ effects. To solve this problem systematically, the scientists described the effects of drugs and diseases in the common language of 'genomic signatures,' meaning the full complement of genes that the drugs turn on and off.

To create a first-generation Connectivity Map, the scientists measured the genomic signatures of more than 160 drugs and other biologically active compounds. They next developed a compu
'"/>




Page: 1 2 3

Related medicine news :

1. Genetic Dentistry: Your Dentist may be able to grow you a new set of Teeth.
2. Genetic influence in menopause
3. Genetics and cholesterol levels
4. Genetics helps in attacking cancer
5. Genetic disorder related with sleep patterns
6. Genetic innovation
7. Genetic tests for cancer
8. Genetic indicates memory
9. Genetic mutation to the fountain of youth discovered
10. Genetic differences found between Male and Female brains
11. Alcoholism Influenced By Both Genetics & Family Environment
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...c Health suggests that obesity can//increase the r...dy existing. Obesity had been conclusively associa... diabetes, and certain forms of cancer. This is fo...ns have been established between obesity and asthm...
...entists its said that it is better// to go for sur...to wait and see if the disease progresses. Surgery...atectomy, is a common procedure. The researchers h...tectomy done in early stages of prostate cancer be...
... gastro esophageal reflux may be due// to wrong ea.... Nocturnal heartburns often lead to disturbed sle...part from being cause of other disease. Nocturnal ...is often linked with severe form of gastro esophag...
...ce that sheds new light on the details of how Hunt...patient. Huntington's disease is a genetic disorde...o think or move on his own. Early symptoms of the ..., forgetfulness, and inability to concentrate or r...
Other Medicine News:
(Date:9/4/2008)...RNewswire-FirstCall/ -- BioForm Medical,Inc. (Nas...ical study of,Polidocanol, conducted in Germany by...SLER & Co. GmbH (Kreussler), successfully met the ...DA as part of a New Drug Application,(NDA) process...(Efficacy and safety of,Aethoxysklerol compared to...
(Date:9/4/2008)...0 Women at More Than 100 Sites in the U.S., ANN A...ceuticals, a,privately-held biopharmaceutical comp...f compounds to treat endocrine, metabolic and,card...initiated a second,Phase 3 clinical trial of Ophen...-free oral therapy in development for the treatmen...
(Date:9/4/2008)...chedule with Two Abstracts Accepted for Presen...r 2008, BRIDGEWATER, N.J., Sept. 4 /...maceutical company focused on the treatment of,car... the appointment of,Peter L. Garrambone, Jr. to th...,s career includes more than 50 pharmaceutical,tra...
(Date:9/3/2008)... from chronically infected Hepatitis C,patients st...arlier in 2008, - Study is the first to show a s...viral effect of therapeutic Hepatitis C vaccinatio... into a second generation, vaccine formulated wit... activation, VIENNA,...
Breaking Medicine Technology:338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Millennium Biotechnologies Group Inc 28MBTG OB 29 Announces Appointment of Mark C Mirken as its President and Chief Operating Officer 525 1Millennium Biotechnologies Group Inc 28MBTG OB 29 Announces Appointment of Mark C Mirken as its President and Chief Operating Officer 525 2Millennium Biotechnologies Group Inc 28MBTG OB 29 Announces Appointment of Mark C Mirken as its President and Chief Operating Officer 525 3Tamoxifen Helps Treat Bipolar Disorder 1086 1Tamoxifen Helps Treat Bipolar Disorder 1086 2Tamoxifen Helps Treat Bipolar Disorder 1086 3Putting stem cell research on the fast track 359 1Putting stem cell research on the fast track 359 2Putting stem cell research on the fast track 359 3Putting stem cell research on the fast track 359 4Ken Sperling to Lead CIGNA HealthCare Retiree Solutions Unit 1079 1Ken Sperling to Lead CIGNA HealthCare Retiree Solutions Unit 1079 2
...ESS WIRE)--Apr 12, 2007 - Affymax, Inc.,(Nasdaq:AF...s Phase,2 clinical trial of Hematide(TM) dosed mon... at the National Kidney Foundation (NKF),2007 Spri...ance-switch trial in patients previously treated w...ated that mean,hemoglobin (Hgb) levels can be main...
...The costs of eradicating,poliomyelitis from the re...t term, are much lower than the long term costs of... And a recently developed,monovalent vaccine is al...iomyelitis than an existing trivalent vaccine. The...ne and in an upcoming,issue of The Lancet. , Both ...
Other Medicine Technology:Affymax Announces Results From Phase 2 Clinical Trial of Hematide,for the Treatment of Anemia in Dialysis Patients 2Affymax Announces Results From Phase 2 Clinical Trial of Hematide,for the Treatment of Anemia in Dialysis Patients 3Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 2Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 3
...xpensive of the series. It has the ability to phot... of the cornea. The model comes with a 9 high-reso... of a patients corneal endothelium, you simply ask...rest. The left side of the chin rest allows you to...
The simplest, most accurate Ortho-K lens fitting system ever!
...ogy (oprifocon A) Contact Lenses are rigid gas per...process that temporarily corrects nearsightedness ... and removes them in the morning. During the day, ...y reduced., ,The Euclid Systems Orthokeratology (o...
...ontact lenses used for corneal refractive therapy,...ss (myopia). The patient wears the lenses overnigh...uring the day, nearsightedness is corrected or gre...ct lenses apply slight pressure to the center of t...
Medicine Products: